Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 3 2Phase 2 1Phase 1/2 1

Status

Completed 3

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Gastrointestinal 1Endocrine 1Breast 1

Conditions

Urinary Bladder Neoplasms 2Prostatic Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Breast Neoplasms 1Adrenocortical Carcinoma 1

Interventions

pembrolizumab 93Nivolumab 61Docetaxel 55Cyclophosphamide 49enzalutamide 44Magnetic Resonance Spectroscopy 33Ipilimumab 33Gemcitabine 32Abiraterone Acetate 30Prednisone 29fludarabine 28Everolimus 27Paclitaxel 25Cisplatin 24Radiotherapy 23Carboplatin 23Sunitinib 22cabozantinib 21atezolizumab 20Radiosurgery 20Specimen Handling 19Sorafenib 18Bevacizumab 18pazopanib 17bicalutamide 17abiraterone 17Biopsy 15temsirolimus 14darolutamide 14apalutamide 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Suramin × Genitourinary × Clear all
NCT00006476 2013-06-26

Suramin in Treating Patients With Recurrent Bladder Cancer

National Cancer Institute (NCI)

Phase 1 Completed
15 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00003038 2011-08-03

Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
BreastEndocrineGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma

NCT00001381 2008-03-04

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
18 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡